Phase 2 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 65 years old (inclusive)
- You have a confirmed diagnosis of multiple sclerosis (MS), specifically the relapsing-remitting or secondary progressive type
- You have been on a stable dose of antidepressant medication and MS disease treatment for at least 30 days before joining the study
- Your MS has been stable for at least 30 days, meaning no recent flare-ups, no new changes seen on brain scans, and no recent steroid treatment
- You have a local doctor or healthcare provider who is responsible for your regular care and can be contacted if needed during the study
- You are comfortable using a mobile device and can take part in video sessions remotely
Who may not be able to join:
- You have a history of a neurological condition other than MS (such as stroke, Parkinson's disease, brain injury, epilepsy, or dementia), a major mental health condition (such as bipolar disorder or psychosis), or a serious medical condition (such as heart attack, thyroid disease, diabetes with complications, or irregular heart rhythm)
- You have used any nicotine products, such as cigarettes or vaping, in the past 6 months
- You are currently pregnant, breastfeeding, or planning to become pregnant during the study period — and if you could become pregnant, you would need to use an accepted form of birth control throughout the study
- You have had a seizure or been diagnosed with a seizure disorder within the past 5 years
- You have any metal in your head or neck area (not including dental fillings), or you have an implanted medical device such as a pacemaker, defibrillator, or nerve stimulator
- You have an active skin condition or sensitive skin in the area where electrodes (small sensors) would be placed on your body
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Leigh Charvet, PhD, NYU Langone Health
Phone: 929-455-5104
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Hamilton Depression Rating Scale (HDRS-17); Change in Hamilton Depression Rating Scale (HDRS-17)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.